Clinical Trial Update: Xenon Inhalation for Treatment of Posttraumatic Stress Disorder [Phase 2, Phase 3]

View source ↗

Summary

Trial update for xenon inhalation treatment in PTSD covering Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Xenon inhalation therapy (xenon)

Snippet

Sponsor: Nobilis Therapeutics Inc. | Conditions: Post Traumatic Stress Disorder | Phase 2, Phase 3 | Status: UNKNOWN